April 29, 2026 HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
April 29, 2026 First Atlantic Nickel & Cobalt Welcomes Dr. Douglas Wicks, Former Program Director for the U.S. Department of Energy’s ARPA-E (Advanced Research Projects Agency-Energy) Miner Program and Geologic Hydrogen Portfolio, as Strategic Advisor
